The S&P/ASX 200 Index (ASX: XJO) is down 1.5% on Monday, with these five ASX 200 shares falling to new 52-week-plus lows.
Two of the underperforming companies are in the technology sector, two are in healthcare, while the fifth is a major property developer.
Here’s what’s happening.
Two ASX 200 tech shares dropping to fresh one-year-plus lows
The first company making this rather ignominious list today is WiseTech Global Ltd (ASX: WTC).
Shares in the logistics software solutions company are down 5.1% in late morning trade today, changing hands for $36.42 each. That sees the WiseTech share price down 55.2% over 12 months and trading at its lowest level since June 2022.
WiseTech shares have come under pressure over the past months amid increasing concerns that artificial intelligence (AI) could soon be able to deliver much of the same services the company offers at materially cheaper costs.
Which brings us to the second ASX 200 share trading at 52-week-plus lows today, Xero Ltd (ASX: XRO).
Shares in the business and accounting software provider are down 4.9% at the time of writing, trading for $69.25 apiece. This puts the Xero share price down 55.3% over 12 months and trading at its lowest level since November 2022.
Like WiseTech, Xero shares are facing negative investor sentiment amid the rapid rise of AI technologies.
Two ASX 200 healthcare shares sinking to new 52-week lows
Moving on to the healthcare space, we have Sigma Healthcare Ltd (ASX: SIG).
Shares in the retail pharmacy giant, which merged with Chemist Warehouse in 2025, are down 0.6% today, trading for $2.605 each. That sees the Sigma Healthcare share price down 9.6% in a year and at its lowest level since December 2024, prior to the merger.
ResMed Inc (ASX: RMD) shares are also doing it tough.
Shares in the sleep disorder treatment company are down 1.3% today, changing hands for $31.925 each. That puts this ASX 200 share down 8.7% over 12 months and trading at its lowest level since August 2024.
As for the property development giantâ¦
Interest rates may be biting
Stockland Corp Ltd (ASX: SGP) shares join our list of stocks slumping to new one-year-plus lows today.
Shares in the diversified property development company are down 1.4% on Monday, trading for $4.20 each. That puts this ASX 200 share down 14.3% over 12 months and trading at its lowest level since January 2025.
Like many real estate companies, Stockland shares have faced headwinds amid resurgent global inflation and expectations of higher interest rates to come. Real estate stocks tend to perform better in low and falling interest rate environments.
The post 5 ASX 200 shares including WiseTech and Xero plumbing new 52-week-plus lows on Monday appeared first on The Motley Fool Australia.
Should you invest $1,000 in ResMed Inc. right now?
Before you buy ResMed Inc. shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and ResMed Inc. wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- Got $5,000 to invest? Here are 2 ASX tech stocks to buy today
- 2 ASX shares highly recommended to buy: Experts
- How I’d aim to build a $100,000 ASX share portfolio starting at zero
- 3 ASX 200 shares that could beat the market over the next 10 years
- How to become a millionaire with a $5,000 investment in ASX 200 shares each year
Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended ResMed, WiseTech Global, and Xero. The Motley Fool Australia has positions in and has recommended ResMed, WiseTech Global, and Xero. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.